Random triples
| Subject | Object |
|---|---|
| gptkb:Remsima | ongoing monitoring |
| gptkb:Hemlibra | ongoing |
| gptkb:Nexo_Brid | monitored by EMA |
| gptkb:Retevmo | ongoing |
| gptkb:Fabrazyme | important for safety monitoring |
| gptkb:lanadelumab | ongoing monitoring |
| gptkb:adalimumab | ongoing monitoring for safety post-marketing |
| gptkb:Edaravone | monitoring adverse effects |
| gptkb:Biosimilar_to_Adalimumab | important |
| gptkb:Rituximab_biosimilars | adverse event reporting |